respiratory syncytial virus vaccine (Novartis)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namerespiratory syncytial virus vaccine (Novartis)
Drug Alias NameRSV vaccine (Novartis)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionEnvelope glycoprotein modulators
TargetsEnvelope glycoprotein
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Vaccines And Diagnostics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Vaccines And Diagnostics Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A